【丹麦】诺和诺德基金会与英伟达强强联手，打造AI超级计算机助力新药研发
当地时间3月18日，丹麦的诺和诺德基金会，即全球知名医药企业诺和诺德的幕后支持力量，公布了一项重大合作计划。基金会宣布将与全球图形处理单元（GPU）巨头英伟达携手，在丹麦本土建设一台名为“Gefion”的人工智能（AI）超级计算机。这一创新项目旨在利用先进的AI技术加速新药物和治疗方法的发现，以期推动医疗领域的科研进步。
据科创板日报报道，Gefion超级计算机将搭载英伟达的尖端AI平台，为丹麦的公共和私营部门研究人员提供强大的计算能力。这一合作旨在整合生物信息学、药物化学和临床研究等多个领域的数据，通过AI的深度学习和模式识别能力，高效筛选潜在的药物靶点，缩短新药研发周期，降低研发成本。
诺和诺德基金会与英伟达的这一合作，标志着在医疗科技领域的一次重要突破，将有望开启新药研发的新篇章。此举不仅将惠及丹麦的科研环境，也将对全球医疗健康行业产生深远影响，为未来的疾病治疗提供更多的可能性和希望。双方表示，期待Gefion超级计算机能够成为全球医疗AI研究的典范，为人类健康事业作出重大贡献。
英语如下：
**News Title:** “Novo Nordisk Foundation and NVIDIA Join Forces: Creating an AI Supercomputer to Revolutionize Drug Discovery”
**Keywords:** AI Supercomputer, Novo Nordisk, Drug Discovery
**News Content:**
**Denmark** – The Novo Nordisk Foundation, the driving force behind the renowned global pharmaceutical company Novo Nordisk, has announced a major collaboration with NVIDIA, the global leader in graphics processing units (GPUs). The partnership will see the establishment of an AI supercomputer named “Gefion” in Denmark, specifically designed to accelerate the development of new drugs and therapies.
On March 18th, the Foundation revealed that it will team up with NVIDIA to build this cutting-edge AI system on home soil. The initiative aims to harness advanced AI technologies to expedite the discovery of novel medications and treatments, fostering advancements in medical research.
As reported by the科创板 Daily, the Gefion supercomputer will be equipped with NVIDIA’s state-of-the-art AI platform, providing powerful computational capabilities to researchers from both the public and private sectors in Denmark. The collaboration intends to integrate data from bioinformatics, medicinal chemistry, and clinical research, utilizing AI’s deep learning and pattern recognition capabilities to efficiently screen potential drug targets, thereby reducing drug development timelines and costs.
This partnership between the Novo Nordisk Foundation and NVIDIA marks a significant breakthrough in medical technology and is poised to usher in a new era in drug discovery. It will not only benefit Denmark’s research landscape but also have far-reaching implications for the global healthcare industry, offering more possibilities and hope for future disease treatments. Both parties expressed their anticipation that the Gefion supercomputer will serve as a global benchmark for medical AI research, making substantial contributions to human health.
【来源】https://www.chinastarmarket.cn/detail/1624366
Views: 1